Market Read®

  • Tuesday, October 13 2015

This prediction has passed its maturity date!

This prediction was valid between September 21, 2015 and October 06, 2015. All information in this report is for reference only and should not be considered forward looking.


Orexigen Therapeutics


Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its product candidates include NB32, which has completed Phase III clinical trials and is being studied in a cardiovascular outcomes trial; and Empatic that has completed Phase II clinical trials. Orexigen Therapeutics, Inc. has collaboration agreement with Takeda Pharmaceutical Company Limited to develop and commercialize NB32 in the United States, Canada, and Mexico. The company was founded in 2002 and is headquartered in La Jolla, California.

Investment Highlights

  • PATTERN SCAN predicts the price of OREX expected to move down in the coming weeks based on the appearance of a 'Volume Climax' pattern. Specifically, a Trending (Stocks) DO variant of Volume Climax has been detected. The target is $2.26. more
  • SEASONALITY expects the price of OREX expected to move down to $2.21 by September 24, 2015. more
  • VALUATION OREX has a current calculated value of $0.64 which means the stock is overvalued compared to its price of $2.54.

Predictive Range September 15, 2015 - October 06, 2015

Anticipated price movement, between prediction date and target date, based on all market reads.
$2.45 - $2.23

How WealthMakers Market Reads Work:

WealthMakers Market Reads™ provide you with market performance predictions based on proprietary technologies, trading algorithms and data to help you make better, more informed investment decisions. Here's a quick review of our predictive technologies:

  • EARNINGS Most stock price histories show random or unpredictable movements around earnings reports. But some repeat the same pattern quarter after quarter, year after year. Earnings predicts probability, price move and length of move before and after all US stock earnings reports.
  • FRICTION FACTOR Friction Factor is based on the relationship between the price of a stock and the volume at which it's bought and sold. Normal and abnormal Friction factor patterns can help you time your buying and selling decisions for maximum earnings potential.
  • GATS The Global Automated Trading System (GATS) combines neural networks and genetic algorithms to reduce investment risks. GATS selects the highest probability trades in stocks, bonds, options, commodities, currencies and private equities, delivering precise, predictive and profitable data.
  • GROUP SECTOR Certain institutions can exert buying or selling pressure over an entire industry group, pushing prices higher. Group Sector identifies stocks that most closely match their group's movement and generate powerful group consensus trading signals to help you profit from the herd mentality.
  • PATTERN SCAN This technology automatically tracks "Trigger Events" that positively or negatively affect the value of a stock — or its perceived value among analysts — ranging from price fluctuations to natural disasters and political shifts. The results reveal patterns that can predict market movements.
  • EVENTS Events describe the current technical situation in your stock. It displays the technicals, trend conditions and seasonal factors and automatically discovers how that stock has performed in the trading days following the occurrences of the event or combination of events. This technology automatically scans using complex historical queries based on what event is taking place right now in the stock. It then displays the probability, expected return and number of trading days for the expected move.
  • RegSHO NAKED SHORTS SEC Regulation SHO mandates that if a clearing agent holds a fail-to-deliver position for 13 consecutive settlement days, it must purchase securities to close out its position, a.k.a. a forced cover. WealthMakers aggregates data from NYSE, AMEX, NASDAQ, OTCBB and PINKSHEETS to track stocks that are about to have forced covers.
  • SEASONALITY Seasonality analyzes more than 20 years of data to determine if stocks have a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias.
  • SQUEEZE TRIGGER Our proprietary database of more than 3,500,000,000 short sale transactions allows us to calculate the exact price at which the total short interest is short in each stock. Squeeze Trigger Alerts let you know exactly when a short squeeze will start and how to trade profitably.
  • VALUATION A stock's value is a function of its forecasted earnings per share and forecasted earnings growth, as well as profitability, interest and inflation rates. Valuation use these metrics to determine at what price a stock is undervalued or overvalued, so that you can make investment decisions accordingly.
  • INSIDER Significant stock sales or purchases by company "insiders" (officers or directors) can be a predictor of future price movements — up or down. The Insider strategy tracks these actions and correlates them with historical data to give you an investment edge.

Pattern Scan


Tracks "Trigger Events" that positively or negatively affect the value of a stock.

Orexigen Therapeutics (NASDAQ: OREX) is predicted to go down in coming weeks based on bearish technical trends that have appeared in the recent performance of the stock. OREX has demonstrated Volume Climax strategy Trending (Stocks) DO with a strength of 1.0/5. The higher the strength, the higher the probability of an accurate prediction.

  • The price of OREX expected to move down in the coming weeks.
  • PatternScan has detected that a 'Trending (Stocks) DO' pattern has appeared.
  • Specifically, a Trending (Stocks) DO variant of Volume Climax has been detected.
  • This indicates a high probablity that OREX will move down in the coming weeks.



Predicts probability and percentage of stock movements based on seasonal factors.

Orexigen Therapeutics (NASDAQ: OREX) is predicted to go down in coming weeks based on bearish trends that appear around this time of the year. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. OREX, currently trading at 2.54 expected to hit $2.21 by September 24, 2015.

  • The price of OREX expected to move down to $2.21 by September 24, 2015.
  • Expected loss of -7.14% from price at time of prediction (2.38).
  • This pattern has held 7.0 of the last 8.0 seasonal periods. (87.50%)

Squeeze Trigger


We have a proprietary database of all trading in US stocks and maintain massive databases of short sale and naked short sale time and sales data, along with short squeeze SqueezeTrigger prices. We are the only firm that knows the exact price that a short squeeze will start in every US stock.

The Cumulative Squeeze Trigger price for OREX is 5.27.

Date Short Volume Short Value SqueezeTrigger
2015-09-30 8848639 23101141.8373 2.6107
2015-08-31 11098036 39720980.6476 3.5791
2015-07-31 8761905 38117791.512 4.3504
2015-06-30 11169456 53710563.0672 4.8087
2015-05-31 14462399 81557806.6807 5.6393
2015-04-30 12502289 95700021.3794 7.6546
2015-03-31 56478835 410635017.751 7.2706
2015-02-28 5166133 28458160.2438 5.5086
2015-01-31 13403074 74515730.2104 5.5596
2014-12-31 19066079 114331649.331 5.9966
2014-11-30 17391195 86441195.628 4.9704
2014-10-31 16618100 64817237.24 3.9004
2014-09-30 15733763 89178968.684 5.668
2014-08-31 1716748 8550435.0888 4.9806
2014-07-31 18146959 99545143.5945 5.4855
2014-06-30 25802795 161215863.16 6.248
2014-05-31 18128828 104304211.898 5.7535
2014-04-30 3578886 22008001.5684 6.1494
2014-03-31 2300079 16188876.0336 7.0384
2014-02-28 11335655 77666240.2325 6.8515

Friction Factor


Friction Factor determines if there is normal or abnormal behavior in the price action of the stock when compared to the buying vs. selling trading statistics. It shows us how many more shares of buying than selling it takes to move a stock higher by 1 cent, or how many more shares of selling than buying it takes to drop a stock by 1 cent.
Here is how to understand Friction Factor:

  • If Friction Factor is positive, more buying than selling caused OREX's price to rise
  • If Friction Factor is negative, more selling than buying caused OREX's price to fall
  • If Friction Factor is 0, there was no discernable activity either way
  • If Friction Factor is abnormal, it means that more buying than selling caused the price to drop which is evidence of manipulative activity. In some cases more selling than buying can cause the price to increase. While this is rare, it must be noted as well. Friction Factor raw data.

Date Change Buy Vol Sell Vol Net Vol Friction
2015-09-18 -0.06 6274800 1303137 4971663 Bearish Bias
2015-09-17 0.01 628016 597261 30755 30755
2015-09-16 -0.11 686528 793114 -106586 -9689.636364
2015-09-15 -0.02 535821 683674 -147853 -73926.5
2015-09-14 0.02 2150037 2098138 51899 25949.5
2015-09-11 -0.46 2488386 2964233 -475847 -10344.5
2015-09-10 0.29 2451154 2304299 146855 5063.965517
2015-09-09 -0.02 480850 824456 -343606 -171803
2015-09-08 0.01 537048 527035 10013 10013
2015-09-04 -0.11 634542 715427 -80885 -7353.181818
2015-09-03 0.01 497343 598265 -100922 Bullish Bias
2015-09-02 0.06 496444 720876 -224432 Bullish Bias
2015-09-01 -0.09 983111 1048720 -65609 -7289.888889
2015-08-31 -0.12 400519 539072 -138553 -11546.08333
2015-08-28 0.13 541071 698528 -157457 Bullish Bias
2015-08-27 0.06 696722 704950 -8228 Bullish Bias
2015-08-26 0.03 823257 614739 208518 69506
2015-08-25 -0.04 999597 1353468 -353871 -88467.75
2015-08-24 -0.29 1095257 918960 176297 Bearish Bias
2015-08-21 -0.03 734998 793226 -58228 -19409.33333



Value is a measure of a stock's current worth. OREX has a current value of 0.64 per share. Therefore, it is overvalued compared to its Price of $2.54 per share. Value is computed from forecasted earnings per share, forecasted earnings growth, profitability, interest, and inflation rates. Value increases when earnings, earnings growth rate and profitability increase, and when interest and inflation rates decrease.

General Results


Past success in predictions regarding all predictions on the WealthMakers platform.

Our prediction engine has a track record that is second to none. See for our results.

Read Type Avg Return Avg Maturity Days Hits Misses % Accurate
Insider 16.588 82.48 13309 578 95.84%
SqueezeTrigger 12.43 21.55 10020 689 93.57%
Valuation 14.484 26.96 4201 302 93.29%
Seasonality 7.287 15.2 53861 5037 91.45%
Group Correlation 6.846 14.97 7960 845 90.40%
PatternScan 8.466 11.43 202410 29795 87.17%
Events 6.823 11.27 4323 660 86.75%
Earnings 8.51 10.35 24507 4911 83.31%
GATS 5.41 7.86 71249 14763 82.84%
Naked Shorts 13.719 10.93 2800 721 79.52%
Friction Factor 7.07 3.63 7603 2175 77.76%

About Wealthmakers

WealthMakers gives institutional and individual investors an exclusive advantage in making precise, predictive and profitable trading decisions. Our proprietary technologies — Earnings, Seasonality, Squeeze Trigger, Group Sector and GATS — apply artificial intelligence, proprietary algorithms, market data and research to help our clients realize exponential returns. Find out more at

All material herein was prepared by WealthMakers, based upon information believed to be reliable. The information contained herein is not guaranteed by WealthMakers to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. WealthMakers is not a registered investment advisor in the State of California. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. WealthMakers or its affiliates may receive compensation from independent third parties, or from the companies mentioned, for data provided in this report or related services. WealthMakers affiliates, officers, directors and employees do not own shares of the company mentioned in this report, but may from time to time buy/sell the shares discussed in this opinion and may profit from those trades. Market commentary provided by Thomas Ronk, a registered investment advisor and commodities trading advisor in California. WealthMakers will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment.

All Rights Reserved. Copyright 2011 WealthMakers

Last Price$2.54
52 Week Range$4.59 - $7.84
1 Month Range$5.00 - $6.34
Avg Daily Volume2766715.0
PE Ratio0.0
Earnings Per Share
Shares Outstanding116MM
Market Capitalization$654.90MM


ACCOUNT SUPPORT 855-879-3258